Business

Indian Pharma Industry Sees Robust Sustainable Growth And Innovation In 2024

The Indian pharma industry has established itself as a key driver of knowledge for the nation’s economy. With this, the industry is estimated to be US$58 billion, with equal contributions from exports and the domestic market.

Indian pharma is a manufacturing hub of the world with a 20% contribution to global generics sales. With this year ending, there has been robust sustainable growth and a thrust on simplifying regulations and harmonisation with global standards.

Sustainable Growth & Policy Reforms in 2024

The year 2024 has proven to be a turning point for the Indian pharma sector. Building on its strong foundation, the industry has focused on achieving sustainable growth. A key aspect of this growth has been the government’s efforts to simplify regulations and align with global standards.

Notably, the Production Linked Incentive (PLI) schemes have already begun showing positive results, with new green-field projects for the production of Penicillin G and Clavulanic acid, among others. This is vital for enhancing healthcare security and ensuring a diversified supply chain.

Fostering Innovation And R&D Investment

Looking ahead, innovation will continue to be a central theme in India’s pharmaceutical growth. The government is expected to soon announce the operational details of its Promotion of Research & Innovation Programme.

It is designed to spur innovation across the sector. Companies are increasingly focusing on speciality portfolios and diversifying into high-value drugs. Products such as Nafithromycin and Saroglitazar are set to lead the charge in India’s research wave, with government-led committees dedicated to streamlining regulatory reforms that will create a more conducive environment for R&D.

Looking ahead, the Indian pharmaceutical market is expected to grow significantly, with projections indicating it will reach US$120-130 billion by 2030, up from the current size of US$58 billion.

The continued focus on quality, innovation, and expanding global reach will help India’s pharmaceutical sector unlock its full potential. With favourable policies, India is set to play a pivotal role in advancing global healthcare for years to come.

Also Read: India’s IPO Market Achieves Historic Milestone In 2024

Purnima Mishra

Recent Posts

“A Surge of Emotion In The Ocean Of Sanatan Dharma,” Acharya Pramod Krishnam Meets Pandit Dhirendra Shastri

Posting a photo of the meeting on the social media platform X, Acharya Pramod Krishnam…

3 hours ago

Asian Geography Conference Champions Youth As Vanguards Of National Development

Colonel Mustafa urges youth to use geography actively for disaster management, policy, and national development.

5 hours ago

India Sends Record 111-Member Squad To Deaflympics 2025 In Tokyo

India names a record 111-member team for Deaflympics 2025, competing across 11 sports disciplines.

6 hours ago

PM Modi, Leaders Extend Birthday Wishes to Bharat Ratna LK Advani

PM Modi, Amit Shah, and leaders extend birthday wishes to Bharat Ratna LK Advani.

6 hours ago

Justice Vikram Nath Hails PM Modi’s Vision For Accessible & Technology-Driven Justice At NALSA Conference

Justice Vikram Nath praised PM Modi’s vision for inclusive, tech-driven justice and legal empowerment.

7 hours ago

Justice Surya Kant Calls For Empathetic Tech-Driven Legal Aid System At NALSA Conference

Justice Surya Kant urged empathetic, tech-driven legal aid reforms to make justice accessible and inclusive.

7 hours ago